Anakinra in children and adults with Still’s disease

Predictors of Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis

(2019) Benedetta Saccomanno et al.   JOURNAL OF RHEUMATOLOGY

Treat-to-target using first-line recombinant interleukin-1 receptor antagonist monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five year follow-up study

(2019) Nienke M. ter Haar et al.   Arthritis & Rheumatology

Complications of adult-onset Still’s disease and their management

(2018) Stéphane Mitrovic et al.   Expert Review of Clinical Immunology

Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany

(2018) Claas H. Hinze et al.   Pediatric Rheumatology

Reversal of Sepsis-Like Features of Neutrophils by Interleukin-1 Blockade in Patients With Systemic-Onset Juvenile Idiopathic Arthritis

(2018) Nienke M. ter Haar et al.   Arthritis & Rheumatology

Mechanisms, biomarkers and targets for adult-onset Still’s disease

(2018) Eugen Feist et al.   Nature Reviews Rheumatology

Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus

(2018) Alberto Martini et al.   JOURNAL OF RHEUMATOLOGY

Treatment of refractory adult onset Still’s disease with combination anakinra and baricitinib therapy

(2018) Chayma Ladhari et al.   RHEUMATOLOGY

Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets?

(2017) Piero Ruscitti et al.   Expert Review of Clinical Immunology

Review: Genetics and the Classification of Arthritis in Adults and Children

(2017) Peter A. Nigrovic et al.   Arthritis & Rheumatology

Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study

(2017) Serena Colafrancesco et al.   Frontiers in Pharmacology

Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases

(2016) A Hinks et al.   ANNALS OF THE RHEUMATIC DISEASES

Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications

(2016) Michael J Ombrello et al.   ANNALS OF THE RHEUMATIC DISEASES

2016 update of the EULAR recommendations for the management of early arthritis

(2016) Bernard Combe et al.   ANNALS OF THE RHEUMATIC DISEASES

A retrospective study of patients with adult-onset Still’s disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?

(2016) Francesca Dall’Ara et al.   CLINICAL RHEUMATOLOGY

Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients

(2016) Paolo Sfriso et al.   CLINICAL RHEUMATOLOGY

Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes

(2016) Torbjörn Kullenberg et al.   RHEUMATOLOGY

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study

(2016) Antonio Vitale et al.   Frontiers in Pharmacology

Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden Early Arthritis Clinic and ESPOIR cohorts

(2015) J A B van Nies et al.   ANNALS OF THE RHEUMATIC DISEASES

Anakinra in Systemic Juvenile Idiopathic Arthritis: A Single-center Experience

(2015) M. Pardeo et al.   JOURNAL OF RHEUMATOLOGY

Management of juvenile idiopathic arthritis: hitting the target

(2015) Claas Hinze et al.   Nature Reviews Rheumatology

Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey

(2015) Linda Rossi-Semerano et al.   Orphanet Journal of Rare Diseases

Gene-expression analysis of adult-onset Still’s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity

(2015) Nanguneri Nirmala et al.   Pediatric Rheumatology

Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis

(2015) Peter A. Nigrovic   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ

(2015) Karen Put et al.   RHEUMATOLOGY

Efficacy and safety of biological agents in adult-onset Still’s disease

(2015) G Cavalli et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among C

(2015) Sarah Ringold et al.   ARTHRITIS AND RHEUMATISM

The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort

(2014) Jaime Guzman et al.   ANNALS OF THE RHEUMATIC DISEASES

Adult-onset Still's disease

(2014) Mathieu Gerfaud-Valentin et al.   AUTOIMMUNITY REVIEWS

Update on research and clinical translation on specific clinical areas: From bench to bedside: How insight in immune pathogenesis can lead to precision medicine of severe juvenile idiopathic arthritis

(2014) Sebastiaan Vastert et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Pathogenesis of adult-onset Still’s disease: new insights from the juvenile counterpart

(2014) Yvan Jamilloux et al.   IMMUNOLOGIC RESEARCH

Adult-Onset Still Disease

(2014) Mathieu Gerfaud-Valentin et al.   MEDICINE

Adding Canakinumab to the Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Systemic Juvenile Idiopathic Arthritis: Comment on the Article by DeWitt et al

(2014) Yukiko Kimura et al.   ARTHRITIS CARE & RESEARCH

Review: Is There a Window of Opportunity for Treatment of Systemic Juvenile Idiopathic Arthritis?

(2014) Peter A. Nigrovic   Arthritis & Rheumatology

Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis

(2013) Daniel J. Lovell et al.   ARTHRITIS AND RHEUMATISM

Patients with Very Early-onset Systemic Juvenile Idiopathic Arthritis Exhibit More Inflammatory Features and a Worse Outcome

(2013) R. A. G. RUSSO et al.   JOURNAL OF RHEUMATOLOGY

Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study

(2013) Sebastiaan J. Vastert et al.   Arthritis & Rheumatology

Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes

(2013) Saik Urien et al.   BMC Pharmacology & Toxicology

Biological treatment in adult-onset Still's disease

(2012) Jacques Pouchot et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study

(2012) D. NORDSTROM et al.   JOURNAL OF RHEUMATOLOGY

Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

(2012) Nicolino Ruperto et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evanescent and Persistent Pruritic Eruptions of Adult-Onset Still Disease: A Clinical and Pathologic Study of 36 Patients

(2012) Julia Yu-Yun Lee et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Anakinra in Adult-Onset Still's Disease: Long-Term Treatment in Patients Resistant to Conventional Therapy

(2012) Cecilia Giampietro et al.   ARTHRITIS CARE & RESEARCH

A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features

(2011) Nicolino Ruperto et al.   ARTHRITIS AND RHEUMATISM

Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions

(2011) Elizabeth D. Mellins et al.   Nature Reviews Rheumatology

American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis

(2011) Carol A. Wallace et al.   ARTHRITIS CARE & RESEARCH

Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study

(2011) Katerina Laskari et al.   ARTHRITIS RESEARCH & THERAPY

IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease

(2010) L Naumann et al.   ANNALS OF THE RHEUMATIC DISEASES

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

(2010) P. Quartier et al.   ANNALS OF THE RHEUMATIC DISEASES

Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series

(2010) Peter A. Nigrovic et al.   ARTHRITIS AND RHEUMATISM

Adult-onset Still's disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra

(2010) Bernd Raffeiner et al.   JOINT BONE SPINE

Reactive Hemophagocytic Syndrome in Adult-Onset Still Disease

(2010) Arnaud Hot et al.   MEDICINE

Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients

(2010) P. M. Miettunen et al.   RHEUMATOLOGY

Anakinra for Rheumatoid Arthritis: A Systematic Review

(2009) M. MERTENS et al.   JOURNAL OF RHEUMATOLOGY

Differential cytokine profiles in juvenile idiopathic arthritis subtypes revealed by cluster analysis

(2009) Henk-Jan van den Ham et al.   RHEUMATOLOGY

The pattern of response to anti–interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis

(2008) Marco Gattorno et al.   ARTHRITIS AND RHEUMATISM

Adult-onset Still disease

(2008) Bruno Fautrel   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study

(2008) Norman Ilowite et al.   CLINICAL RHEUMATOLOGY